Clinical Trials for Advanced Solid Tumours

Find clinical trials for advanced solid tumours. Discover research opportunities and treatment options in your area.

12 Active Trials Found

Showing 12 trials on this page

Page 1 of 1

Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

NCT ID: NCT06795412

This clinical trial is investigating a new treatment called PYX-201 combined with another drug called pembrolizumab for patients with advanced solid tumors, which are types of cancer that form in d...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Fairfax, Virginia, United States +1 more

A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation

NCT ID: NCT06599502

This clinical trial is exploring a new treatment called AZD0022 for adults with certain advanced cancers that have a specific genetic mutation known as KRASG12D. The study aims to find out how safe...

Recruiting

Phase: PHASE1 Type: interventional Locations: Barcelona, , Spain, Los Angeles, California, United States +39 more

A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z

NCT ID: NCT06929260

This clinical trial is studying a new medication called ceralasertib to see how it affects other treatments known as Drug X, Drug Y, and Drug Z in patients with advanced solid tumors, which are can...

Recruiting

Phase: PHASE1 Type: interventional Locations: Madrid, , Spain, Manchester, , United Kingdom +1 more

First in Human Study of AZD9592 in Solid Tumors

NCT ID: NCT05647122

This clinical trial, called the First in Human Study of AZD9592, is exploring a new treatment for patients with advanced solid tumors, including types of lung, head and neck, and colorectal cancers...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, New York, New York, United States +46 more

A Study of EBC-129 in Advanced Solid Tumours

NCT ID: NCT05701527

This clinical trial is studying a new treatment called EBC-129 for patients with advanced solid tumors, which are types of cancer that have spread or cannot be surgically removed. The trial aims to...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Taipei, , Taiwan +4 more

A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

NCT ID: NCT06815575

This clinical trial is evaluating a new treatment called RC220, both on its own and combined with a standard chemotherapy drug called doxorubicin, for adults with advanced solid tumors. The study a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Gosford, New South Wales, Australia, Miranda, New South Wales, Australia +2 more

A Phase 1/2 Study of [225Ac]-FPI-1434 Injection

NCT ID: NCT03746431

This clinical trial is studying a new treatment called [225Ac]-FPI-1434 Injection for patients with advanced solid tumors, including types like endometrial, cervical, ovarian, and breast cancers. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Adelaide, South Australia, Australia +15 more

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors.

NCT ID: NCT06927349

This clinical trial is studying a new treatment called BA1301 for patients with advanced solid tumors, which are types of cancer that have spread and cannot be surgically removed. The goal of the t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Harbin, Heilongjiang, China

A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours

NCT ID: NCT06868199

This clinical trial is exploring a new medication called LM-168, both on its own and in combination with another drug called toripalimab, for patients with advanced solid tumors. The main goals of ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Birtinya, Queensland, Australia, Wollongong, New South Wales, Australia

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT ID: NCT06380816

This clinical trial is testing a new drug called UCB4594 in people with advanced cancer. UCB4594 is a monoclonal antibody, which means it's designed to attach to a specific protein found in high am...

Recruiting

Phase: PHASE1 Type: interventional Locations: Manchester, , United Kingdom, Southampton, , United Kingdom

A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours

NCT ID: NCT05804526

This clinical trial is studying a new treatment called RC88, which is combined with another drug named Sintilimab, for patients with advanced solid tumors. The main goals of the study are to check ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours

NCT ID: NCT05537051

This clinical trial is studying a new treatment for patients with advanced solid tumors, which are types of cancers that have spread and are harder to treat. The researchers want to find out how sa...

Not yet recruiting

Phase: PHASE1 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions